Cellcolabs vs Xinteza API
Cellcolabs vs Xinteza API, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellcolabs is on 55/100 and Xinteza API on 42/100.
Where each one leads
Cellcolabs
- our overall score: 55/100 against 42/100
- agent readiness: 40/100 against 21/100
- domain rating: 36/100 against 1/100
- headcount: 79 against 4
- funding raised: $15.5M against $10.0M
- LinkedIn following: 6,563 against 83
Xinteza API
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Cellcolabs | Xinteza API |
|---|---|---|
| What it is | AI-powered platform for personalized cell therapy development and manufacturing. | Biosynthesis of cannabinoids and psychedelics using advanced biotechnology. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, Cannabis, Genetics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2021 | 2021 |
| Headquarters | Tel Aviv, Israel | San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellcolabs | Xinteza API |
|---|---|---|
| Employees | 79 | 4 |
| Headcount growthLast 12 months | Not published | +10.4% |
| Total funding | $15.5M | $10.0M |
| Latest round | Not published | Seed |
| LinkedIn followers | 6,563 | 83 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellcolabs | Xinteza API |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 42/100 |
| Traction | Not published | 42/100 |
| Team | Not published | 60/100 |
| Search visibility | 2/100 | 18/100 |
| Quality | Not published | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 36/100 | 1/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellcolabs | Xinteza API |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Not detected | Webflow |
| Analytics | Google Tag Manager | Not detected |
Cellcolabs vs Xinteza API: common questions
Which is better, Cellcolabs or Xinteza API?
On our 0-100 score Cellcolabs rates higher (55/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Cellcolabs and Xinteza API compare on the numbers?
Cellcolabs leads on our overall score (55/100 against 42/100), agent readiness (40/100 against 21/100), domain rating (36/100 against 1/100), headcount (79 against 4), funding raised ($15.5M against $10.0M), LinkedIn following (6,563 against 83).
Read the full Cellcolabs review and pricing or the Xinteza API review and pricing. You can also browse other Cellcolabs alternatives we track.